| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.033 | 0.9 |